{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:45:33Z","timestamp":1793274333940,"version":"4.5.0"},"reference-count":205,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Fondazione AIRC","award":["27386"],"award-info":[{"award-number":["27386"]}]},{"name":"Fondazione AIRC","award":["21651"],"award-info":[{"award-number":["21651"]}]},{"name":"Fondazione AIRC","award":["ECS0000009"],"award-info":[{"award-number":["ECS0000009"]}]},{"name":"Fondazione AIRC","award":["PNC0000003"],"award-info":[{"award-number":["PNC0000003"]}]},{"name":"Italian Minister of Health","award":["H53C22000650006"],"award-info":[{"award-number":["H53C22000650006"]}]},{"name":"Italian Minister of Health","award":["H53C22000800006"],"award-info":[{"award-number":["H53C22000800006"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Targets"],"DOI":"10.1080\/14728222.2026.2748743","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:24:29Z","timestamp":1792679069000},"page":"1-19","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Molecular advancements in targeting fibroblast activation protein (FAP) in cancer therapies"],"prefix":"10.1080","author":[{"given":"Marianna","family":"Talia","sequence":"first","affiliation":[{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Scordamaglia","sequence":"additional","affiliation":[{"name":"\u201cKore\u201d University of Enna","place":["Enna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Gian\u00ec","sequence":"additional","affiliation":[{"name":"\u201cKore\u201d University of Enna","place":["Enna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cirillo","sequence":"additional","affiliation":[{"name":"\u201cKore\u201d University of Enna","place":["Enna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Panza","sequence":"additional","affiliation":[{"name":"University \u201cMagna Gr\u00e6cia\u201d of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Occhiuzzi","sequence":"additional","affiliation":[{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina Assunta","family":"Mondino","sequence":"additional","affiliation":[{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Silvestri","sequence":"additional","affiliation":[{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azzurra","family":"Zicarelli","sequence":"additional","affiliation":[{"name":"\u201cKore\u201d University of Enna","place":["Enna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Meliti","sequence":"additional","affiliation":[{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Di Dio","sequence":"additional","affiliation":[{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedora","family":"Grande","sequence":"additional","affiliation":[{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Malaguarnera","sequence":"additional","affiliation":[{"name":"\u201cKore\u201d University of Enna","place":["Enna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Paolino","sequence":"additional","affiliation":[{"name":"University \u201cMagna Gr\u00e6cia\u201d of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maggiolini","sequence":"additional","affiliation":[{"name":"University of Calabria","place":["Rende, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernestina Marianna","family":"De Francesco","sequence":"additional","affiliation":[{"name":"\u201cKore\u201d University of Enna","place":["Enna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Lappano","sequence":"additional","affiliation":[{"name":"University \u201cMagna Gr\u00e6cia\u201d of Catanzaro","place":["Catanzaro, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,29]]},"reference":[{"issue":"4","key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/14728222.2013.757305","article-title":"Tumor-stromal interactions in breast tumor progression\u2013significance of histological heterogeneity of tumor-stromal fibroblasts","volume":"17","author":"Hasebe T.","year":"2013","unstructured":"Hasebe T. Tumor-stromal interactions in breast tumor progression\u2013significance of histological heterogeneity of tumor-stromal fibroblasts. Expert Opin Ther Targets. 2013;17(4):449\u2013460.","journal-title":"Expert Opin Ther Targets"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2023.2230362"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01688-0"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0004-1"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.9.6.1217"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-026-01146-x"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07582-3"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1516"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01207-0"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.016"},{"issue":"2","key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1535-7163.MCT-11-0340","article-title":"Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy","volume":"11","author":"Brennen WN","year":"2012","unstructured":"Brennen WN, Isaacs JT, Denmeade SR. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy. Mol Cancer Ther. 2012;11(2):257\u2013266.","journal-title":"Mol Cancer Ther"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-023-01308-9"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728220903103841"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.21.8296"},{"issue":"21","key":"e_1_3_4_17_1","first-page":"5702","article-title":"A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells","volume":"54","author":"Monsky WL","year":"1994","unstructured":"Monsky WL, Lin CY, Aoyama A, et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 1994;54(21):5702\u20135710.","journal-title":"Cancer Res"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.12.7595"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(95)80157-H"},{"issue":"9","key":"e_1_3_4_20_1","first-page":"855","article-title":"Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers","volume":"11","author":"Kelly T","year":"1998","unstructured":"Kelly T, Kechelava S, Rozypal TL, et al. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod Pathol. 1998;11(9):855\u2013863.","journal-title":"Mod Pathol"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09909-3"},{"issue":"20","key":"e_1_3_4_22_1","doi-asserted-by":"crossref","first-page":"19441","DOI":"10.1074\/jbc.C500092200","article-title":"Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha","volume":"280","author":"Aertgeerts K","year":"2005","unstructured":"Aertgeerts K, Levin I, Shi L, et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J Biol Chem. 2005;280(20):19441\u201319444.","journal-title":"J Biol Chem"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2016.05.001"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000591"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4CB00267A"},{"issue":"3","key":"e_1_3_4_26_1","first-page":"1154","article-title":"Identification and characterization of the promoter of fibroblast activation protein","volume":"2","author":"Zhang J","year":"2010","unstructured":"Zhang J, Valianou M, Cheng JD. Identification and characterization of the promoter of fibroblast activation protein. Front Biosci (Elite Ed). 2010;2(3):1154\u20131163.","journal-title":"Front Biosci (Elite Ed)"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.51.36505"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm400351a"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201300095"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2011.08051.x"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.710582"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2017.1370455"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.RA118.001046"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3452"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1006\/prep.2001.1572"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12757"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031046"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04303-3"},{"issue":"3","key":"e_1_3_4_39_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yexmp.2009.09.001","article-title":"TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected]","volume":"87","author":"Chen H","year":"2009","unstructured":"Chen H, Yang W-W, Wen Q-T, et al. TGF-beta induces fibroblast activation protein expression; fibroblast activation protein expression increases the proliferation, adhesion, and migration of HO-8910PM [corrected]. Exp Mol Pathol. 2009;87(3):189\u2013194.","journal-title":"Exp Mol Pathol"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1111511"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652412803833607"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01010"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400381R"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-025-01994-6"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2015.08.016"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202110-2414OC"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2026.02.007"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13392"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom13121718"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1616618"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01957-5"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103261"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64447-2"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29366-6"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262211112"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.32604\/or.2024.046965"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1339050"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-024-01580-4"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00474-w"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2020.1751819"},{"issue":"50","key":"e_1_3_4_61_1","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig C","year":"2013","unstructured":"Feig C, Jones JO, Kraman M, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci USA. 2013;110(50):20212\u201320217.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"e_1_3_4_62_1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling","volume":"76","author":"Yang X","year":"2016","unstructured":"Yang X, Lin Y, Shi Y, et al. FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 2016;76(14):4124\u20134135.","journal-title":"Cancer Res"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-245"},{"issue":"2","key":"e_1_3_4_64_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.abb.2006.11.006","article-title":"Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, iii, and IV","volume":"457","author":"Christiansen VJ","year":"2007","unstructured":"Christiansen VJ, Jackson KW, Lee KN, et al. Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, iii, and IV. Arch Biochem Biophys. 2007;457(2):177\u2013186.","journal-title":"Arch Biochem Biophys"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030545"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113697"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.195776"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.969731"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106600"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2019.07.007"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1068405"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113302"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.72218"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03823-4"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5035-9"},{"key":"e_1_3_4_76_1","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2147\/OTT.S243417","article-title":"Fibroblast activation protein (FAP) overexpression induces epithelial-mesenchymal transition (EMT) in oral squamous cell carcinoma by down-regulating dipeptidyl peptidase 9 (DPP9)","volume":"13","author":"Wu Q-Q","year":"2020","unstructured":"Wu Q-Q, Zhao M, Huang G-Z, et al. Fibroblast activation protein (FAP) overexpression induces epithelial-mesenchymal transition (EMT) in oral squamous cell carcinoma by down-regulating dipeptidyl peptidase 9 (DPP9). Onco Targets Ther. 2020;13:2599\u20132611.","journal-title":"Onco Targets Ther"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00979"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03896-y"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-025-06372-4"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05226-x"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03359-3"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218410"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI166070"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2298"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-21-0183"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2025.01.010"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0150"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217475"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007447"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108537"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07974-6"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2021.1857727"},{"issue":"10","key":"e_1_3_4_93_1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/14728222.2021.2010046","article-title":"Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?","volume":"25","author":"Wang J","year":"2021","unstructured":"Wang J, Loeuillard E, Gores GJ, et al. Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells? Expert Opin Ther Targets. 2021;25(10):835\u2013845.","journal-title":"Expert Opin Ther Targets"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2022.2170779"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265594"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.69475"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14101023"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology13120967"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210435"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.210443"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.224469"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227967"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2025.11.022"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1021\/ml300410d"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220749"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061889"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108445"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13122018"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.1c00566"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.233122"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05554-2"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004260"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.215913"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05307-1"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2019194003"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.253062"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004480"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00299-2"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.245084"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040522"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.34172\/bi.33007"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.07.009"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262468"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14121212"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004164"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-026-00830-z"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06211-6"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06623-y"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.4c00630"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17050552"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108541"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.271452"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5c01707"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1159\/000069863"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:DRUG.0000006173.72210.1c"},{"issue":"5","key":"e_1_3_4_136_1","first-page":"1639","article-title":"A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer","volume":"9","author":"Scott AM","year":"2003","unstructured":"Scott AM, Wiseman G, Welt S, et al. A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003;9(5):1639\u20131647.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00872-z"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-23-0527"},{"issue":"2","key":"e_1_3_4_139_1","doi-asserted-by":"crossref","first-page":"e70020","DOI":"10.1002\/jlcr.70020","article-title":"Preclinical evaluation of [225Ac]Ac-Sibrotuzumab employing a PEG4-macropa site-specific chelation strategy for targeted ablation of cancer-associated fibroblasts in desmoplastic tumors","volume":"69","author":"Shah SQ","year":"2026","unstructured":"Shah SQ, Santos-Oliveira R, Shabnam M, et al. Preclinical evaluation of [225Ac]Ac-Sibrotuzumab employing a PEG4-macropa site-specific chelation strategy for targeted ablation of cancer-associated fibroblasts in desmoplastic tumors. J Labelled Comp Radiopharm. 2026;69(2):e70020.","journal-title":"J Labelled Comp Radiopharm"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-24-0601"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-3567"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105374"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2677"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyag023"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012466"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-1562"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013989"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav5989"},{"issue":"695","key":"e_1_3_4_149_1","doi-asserted-by":"crossref","first-page":"eabp9229","DOI":"10.1126\/scitranslmed.abp9229","article-title":"A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors","volume":"15","author":"Melero I","year":"2023","unstructured":"Melero I, Tanos T, Bustamante M, et al. A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors. Sci Transl Med. 2023;15(695):eabp9229.","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-NB2023-0044"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-026-01157-8"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-24-0717"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-026-01150-1"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2238"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2020.140409"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw186"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0518"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000593"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.121"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1788"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.02.014"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202506038"},{"issue":"1","key":"e_1_3_4_163_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/acs.bioconjchem.4c00503","article-title":"Delivery of monomethyl auristatin F to the tumor microenvironment with noninternalizing fibroblast activation protein-cleavable small molecule-drug conjugates elicits potent in vivo anticancer activity","volume":"36","author":"Bocci M","year":"2025","unstructured":"Bocci M, Principi L, Gilardoni E, et al. Delivery of monomethyl auristatin F to the tumor microenvironment with noninternalizing fibroblast activation protein-cleavable small molecule-drug conjugates elicits potent in vivo anticancer activity. Bioconjug Chem. 2025;36(1):15\u201319.","journal-title":"Bioconjug Chem"},{"issue":"10","key":"e_1_3_4_164_1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1158\/1535-7163.MCT-25-0026","article-title":"Development of multivalent FAP-targeted small molecule-drug conjugates with tailored MMAE release kinetics","volume":"24","author":"Bocci M","year":"2025","unstructured":"Bocci M, Principi L, Neri D, et al. Development of multivalent FAP-targeted small molecule-drug conjugates with tailored MMAE release kinetics. Mol Cancer Ther. 2025;24(10):1487\u20131496.","journal-title":"Mol Cancer Ther"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0488-6"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01207-0"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16505"},{"key":"e_1_3_4_168_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04080-z"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.110"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200817"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1379"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-615"},{"key":"e_1_3_4_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113888"},{"key":"e_1_3_4_174_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2556714"},{"key":"e_1_3_4_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109237"},{"key":"e_1_3_4_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145006"},{"key":"e_1_3_4_177_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1747350"},{"key":"e_1_3_4_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2022.07.008"},{"key":"e_1_3_4_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109946"},{"key":"e_1_3_4_180_1","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1011"},{"key":"e_1_3_4_181_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c00764"},{"key":"e_1_3_4_182_1","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2018.2616"},{"key":"e_1_3_4_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.02.040"},{"key":"e_1_3_4_184_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.122417"},{"key":"e_1_3_4_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2024.100294"},{"key":"e_1_3_4_186_1","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202106296"},{"key":"e_1_3_4_187_1","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500176"},{"key":"e_1_3_4_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.153369"},{"key":"e_1_3_4_189_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.3c00943"},{"key":"e_1_3_4_190_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.6b04150"},{"key":"e_1_3_4_191_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.120283"},{"key":"e_1_3_4_192_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1668199"},{"key":"e_1_3_4_193_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125190"},{"key":"e_1_3_4_194_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101336"},{"issue":"107751","key":"e_1_3_4_195_1","doi-asserted-by":"crossref","first-page":"107751","DOI":"10.1016\/j.phrs.2025.107751","article-title":"Extracellular vesicles as nature\u2019s nano carriers in cancer therapy: insights toward preclinical studies and clinical applications","volume":"217","author":"Wu X","year":"2025","unstructured":"Wu X, Meng Y, Yao Z, et al. Extracellular vesicles as nature\u2019s nano carriers in cancer therapy: insights toward preclinical studies and clinical applications. Pharmacol Res. 2025;217(107751):107751.","journal-title":"Pharmacol Res"},{"key":"e_1_3_4_196_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02064-1"},{"key":"e_1_3_4_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2021.09.003"},{"key":"e_1_3_4_198_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02753-7"},{"key":"e_1_3_4_199_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01382-y"},{"key":"e_1_3_4_200_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116683"},{"key":"e_1_3_4_201_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1716536"},{"key":"e_1_3_4_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.02.028"},{"key":"e_1_3_4_203_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1358"},{"key":"e_1_3_4_204_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2023.05.003"},{"key":"e_1_3_4_205_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01748-z"},{"key":"e_1_3_4_206_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06144-0"},{"key":"e_1_3_4_207_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122344"}],"container-title":["Expert Opinion on Therapeutic Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728222.2026.2748743","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14728222.2026.2748743","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728222.2026.2748743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:53:52Z","timestamp":1793271232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728222.2026.2748743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,29]]},"references-count":205,"alternative-id":["10.1080\/14728222.2026.2748743"],"URL":"https:\/\/doi.org\/10.1080\/14728222.2026.2748743","relation":{},"ISSN":["1472-8222","1744-7631"],"issn-type":[{"value":"1472-8222","type":"print"},{"value":"1744-7631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}